Operating Margin of X4 Pharmaceuticals, Inc from 30 Sep 2019 to 30 Sep 2025

Taxonomy & unit
ratio: %
Description
The operating margin measures the profit a company makes on a dollar of sales after accounting for the direct costs involved in earning those revenues.
Summary
X4 Pharmaceuticals, Inc quarterly and annual Operating Margin in % history and change rate from 30 Sep 2019 to 30 Sep 2025.
  • X4 Pharmaceuticals, Inc Operating Margin for the quarter ending 30 Sep 2025 was -291%.
  • X4 Pharmaceuticals, Inc annual Operating Margin for 2024 was -1424%.
Operating Margin, Quarterly (%)
Operating Margin, YoY Quarterly Change (%)
Operating Margin, Annual (%)

X4 Pharmaceuticals, Inc Quarterly Operating Margin (%)

Period Value YoY Chg Change % Start Date End Date
Q3 2025 -291% 01 Jul 2025 30 Sep 2025
Q2 2025 -323% 01 Apr 2025 30 Jun 2025
Q1 2025 -27% 01 Jan 2025 31 Mar 2025
Q4 2024 -1424% 01 Oct 2024 31 Dec 2024
Q4 2020 -1996% 01 Oct 2020 31 Dec 2020
Q3 2020 -1770% -373% -27% 01 Jul 2020 30 Sep 2020
Q2 2020 -1770% 01 Apr 2020 30 Jun 2020
Q1 2020 -1728% 01 Jan 2020 31 Mar 2020
Q3 2019 -1397% 01 Jul 2019 30 Sep 2019

X4 Pharmaceuticals, Inc Annual Operating Margin (%)

Period Value YoY Chg Change % Start Date End Date
2024 -1424% 01 Jan 2024 31 Dec 2024
2020 -1996% 01 Jan 2020 31 Dec 2020
* An asterisk sign (*) next to the value indicates that the value is likely invalid.